Royal Philips (NYSE:PHG) announced today that it launched its Quicklear mechanical thrombectomy system in the U.S. after receiving FDA clearance. QuickClear is a compact, single-use system designed to provide an all-in-one aspiration pump and catheter for removing blood clots from the vessels of the peripheral arterial and venous systems. It is now available for sale in […]
Angiodynamics launches atherectomy system
AngioDynamics (NSDQ:ANGO) announced today that it launched the Auryon atherectomy system for treating peripheral artery disease (PAD). Latham, N.Y.-based AngioDynamics’ newly developed, FDA-cleared Auryon atherectomy system uses lasers to treat PAD lesions and occlusions, both above and below the knee in any type or length with minimal impact on the vessel walls, according to a news […]
Former Corindus CEO Toland joins medtech investment firm
BioStar Capital announced today that former Corindus Vascular Robotics CEO Mark Toland has joined the firm as a partner and EIR. As a partner and entrepreneur in residence (EIR), Toland is slated to help in the discovery, development and nurturing of new startups with high-growth potential. He will also have the flexibility to function in […]
InspireMD wins FDA approval for carotid stent system study
InspireMD today said it received FDA approval to proceed with a pivotal study of its CGuard Carotid Stent System. The investigational device exemption from the FDA will allow the company to study the device for the prevention of stroke in patients in the U.S. Get the full story on our sister site, Medical Tubing + […]
Boston Scientific stent gains added Medicare coverage
Boston Scientific (NYSE:BSX) announced today that CMS granted a new technology add-on payment (NTAP) for its Eluvia system. Marlborough, Mass.-based Boston Scientific’s Eluvia drug-eluting vascular stent system received the NTAP as part of the 2021 inpatient prospective payment system (IPPS). The NTAP will be made effective on Oct. 1, 2020, to provide eligible hospitals with incremental […]
Abbott launches trial for drug-eluting resorbable scaffold
Abbott (NYSE:ABT) announced today that it started the LIFE-BTK clinical trial for its Espirit BTK everolimus-eluting resorbable scaffold system. According to a news release, Abbott’s Espirit system is the first to begin an investigational device exemption (IDE) trial in the U.S. for a fully resorbable device for treating below-the-knee blocked arteries or critical limb ischemia (CLI) […]
MedTech 100 roundup: Industry reaches new heights again
The past month has seen a resurgence from medtech companies in the markets and last week saw the best performance yet. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 90.78 points at the end of last week (Aug. 28). Overall, medtech stocks saw a 1.3% increase […]
Philips to acquire Intact Vascular for $275M
Royal Philips (NYSE:PHG) announced today that it agreed to acquire Intact Vascular in a deal worth approximately $275 million upfront. Wayne, Pa.-based Intact Vascular makes the Tack specialized implantable device for treating peripheral artery disease (PAD). The Tack endovascular system reinforces standard and drug-coated balloon PAD treatment results as a first-of-its-kind, minimal-metal, dissection repair device for […]
Concept Medical begins DCB trial for peripheral artery disease
Concept Medical announced today that it enrolled the first patient in its Future BTK trial for its peripheral artery disease (PAD) treatment. The first patient was enrolled in Singapore yesterday for the randomized, double-blind, placebo-controlled, multi-center trial for determining the effectiveness of the MagicTouch sirolimus coated balloon compared to standard balloon angioplasty in treating below […]
CHF Solutions closes $14.4M offering
CHF Solutions (NSDQ:CHFS) announced that it closed an underwritten public offering worth gross proceeds of approximately $14.4 million. Eden Prairie, Minn.-based CHF Solutions’ offering includes the full exercise of the underwriters’ over-allotment option to purchase additional shares and warrants, bringing the total proceeds to $14.37 million after the offering was priced last week at approximately $12.5 […]
CHF Solutions prices $12.5M offering
CHF Solutions (NSDQ:CHFS) announced today that it priced an underwritten public offering of units worth approximately $12.5 million. Each unit in the offering consists of one share of common stock and one warrant to purchase one share of common stock at a public offering price of 45¢ per share, which expires on the fifth anniversary […]
- 1
- 2
- 3
- …
- 81
- Next Page »
